Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer
Open Access
- 1 June 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (28) , 44406-44416
Abstract
Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancerKeywords
This publication has 31 references indexed in Scilit:
- Foxm1 Mediates Cross Talk between Kras/Mitogen-Activated Protein Kinase and Canonical Wnt Pathways during Development of Respiratory EpitheliumMolecular and Cellular Biology, 2012
- Signet Ring Cell Histology is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Regardless of Tumoral Clinical PresentationAnnals of Surgery, 2009
- Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathwayCarcinogenesis, 2008
- RETRACTED ARTICLE: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulationBreast Cancer Research and Treatment, 2008
- Down-regulation of Forkhead Box M1 Transcription Factor Leads to the Inhibition of Invasion and Angiogenesis of Pancreatic Cancer CellsCancer Research, 2007
- Clinical experience of MEK inhibitors in cancer therapyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- Risk of tumorigenesis in overgrowth syndromes: A comprehensive reviewAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2005
- Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP CoactivatorsMolecular and Cellular Biology, 2004
- Optimization of a metastasizing human gastric cancer model in nude miceMicrosurgery, 2003
- Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndromeNature Genetics, 1996